Home › NDC Lookup › RxCUI directory › RxCUI 904932

Ibandronic acid 150 MG Oral Tablet — RxCUI 904932

RxNorm drug concept · Semantic clinical drug
RxCUI 904932 Semantic clinical drug · SCD ● Current RxNorm concept 7 FDA products 9 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI904932
Official nameIbandronic acid 150 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asibandronic acid 150 MG (as ibandronate sodium 168.75 MG) Oral Tablet; ibandronate sodium 150 MG Oral Tablet
FDA products mapped7
Package NDCs mapped9
Reported Medicaid activity (SDUD)25,078 prescriptions · 41 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Ibandronate: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Ibandronate is a type of medication called a bisphosphonate. It works by slowing down the cells in your body that break down bone tissue, which helps your bones stay denser and str...
  • What exactly is ibandronate and what is it supposed to do for me?
  • There are a few key steps, and they really matter — skipping them can make the medication less effective or cause stomach and esophageal irritation. Take your tablet first thing in...
  • How do I take the tablet correctly? I've heard there are a lot of rules.
📖 Read our full Ibandronate guide →

🕸️ Concept Web — How Ibandronic acid 150 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Ibandronic acid 150 MG Oral Tablet RxCUI 904932

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Ibandronate 115264
    • Ibandronic acid 115265
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Boniva 541684
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Ibandronate Oral Tablet 452852
    • Ibandronic acid Oral Tablet 2649354
    • Ibandronate Oral Product 1165297
    • Ibandronate Pill 1165298
    • Ibandronic acid Oral Product 2660910
    • Ibandronic acid Pill 2662203
    • Ibandronate Oral Tablet [Boniva] 579527
    • Ibandronic acid Oral Tablet [Boniva] 2658104
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Ibandronic acid 150 MG 904931
    • Ibandronic acid 150 MG Oral Tablet [Boniva] 904934
    • Ibandronic acid 150 MG [Boniva] 904933

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Ibandronic acid 150 MG SCDC · 904931
  • Ibandronate Oral Tablet SCDF · 452852
  • Ibandronic acid Oral Tablet SCDFP · 2649354
  • Ibandronate Oral Product SCDG · 1165297
  • Ibandronate Pill SCDG · 1165298
  • Ibandronic acid Oral Product SCDGP · 2660910
  • Ibandronic acid Pill SCDGP · 2662203

Brand-Name Concepts

  • Ibandronic acid 150 MG Oral Tablet [Boniva] SBD · 904934
  • Ibandronic acid 150 MG [Boniva] SBDC · 904933
  • Ibandronate Oral Tablet [Boniva] SBDF · 579527
  • Ibandronic acid Oral Tablet [Boniva] SBDFP · 2658104
  • Boniva Oral Product SBDG · 1175713
  • Boniva Pill SBDG · 1175714
  • Boniva BN · 541684

📦 FDA Products & Package NDCs

7 products · 9 package NDCs
9 package NDCs map to RxCUI 904932 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
33342-0150-52 1 BLISTER PACK in 1 CARTON (33342-150-52) / 3 TABLET, FILM... IBANDRONATE SODIUM Macleods Pharmaceuticals Limited 2025-07-01
33342-0150-53 3 CARTON in 1 BOX (33342-150-53) / 1 BLISTER PACK in 1 CART... IBANDRONATE SODIUM Macleods Pharmaceuticals Limited 2018-06-13
50090-7654-00 1 BLISTER PACK in 1 CARTON (50090-7654-0) / 3 TABLET in 1 B... Ibandronate sodium A-S Medication Solutions 2025-09-17
55111-0575-03 3 BLISTER PACK in 1 CARTON (55111-575-03) / 1 TABLET in 1 B... Ibandronate sodium Dr. Reddy's Laboratories Limited 2012-06-21
55111-0575-43 1 BLISTER PACK in 1 CARTON (55111-575-43) / 3 TABLET in 1 B... Ibandronate sodium Dr. Reddy's Laboratories Limited 2021-11-20
60429-0643-73 3 BLISTER PACK in 1 PACKAGE (60429-643-73) / 1 TABLET, FILM... IBANDRONATE SODIUM Golden State Medical Supply, Inc. 2016-02-05
60505-2795-00 3 BLISTER PACK in 1 PACKAGE (60505-2795-0) / 1 TABLET, FILM... IBANDRONATE SODIUM Apotex Corp 2012-03-19
65862-0237-03 1 BLISTER PACK in 1 CARTON (65862-237-03) / 3 TABLET, FILM... Ibandronate Sodium Aurobindo Pharma Limited 2016-03-11
69452-0378-74 1 BLISTER PACK in 1 CARTON (69452-378-74) / 3 TABLET in 1 B... IBANDRONATE SODIUM Bionpharma Inc. 2023-05-26
Observed labelers: Dr. Reddy's Laboratories Limited (2) · Macleods Pharmaceuticals Limited (2) · A-S Medication Solutions (1) · Apotex Corp (1) · Aurobindo Pharma Limited (1) · Bionpharma Inc. (1) · +1 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.